CTD2 Network
Dr. Kemp is a member of the Cancer Target Discovery and Development (CTD2) Network working to bridge the knowledge gap between cancer genomics and precision oncology by mining and functionally validating high-throughput, high-content genomic data and translating the finding to the bedside.
CTD2 Network comprised of 12-National Cancer Institute Office of Cancer Genetics-supported research teams, called Centers. The Centers work independentaly and collaboratively. Network Centers utilize a combination of state-of-the-art high throughput informatic and experimental approaches to functionally validate discoveries from genomic studies and advance them toward precision oncology. They share data and resources, such as analytical tools and reagents, across the Network and with the research community.